期刊文献+

不同的血液净化方法治疗肝衰竭疗效分析 被引量:8

Analysis effect of different blood purification treatments in liver failure
下载PDF
导出
摘要 目的评价不同的血液净化方法治疗肝衰竭的疗效。方法选择96例肝衰竭患者,其中男性59例,女性37例;年龄36~73岁,平均年龄49.46岁。前瞻性随机分为4组进行不同方法的血液净化治疗(血液滤过、血液灌流、血浆置换),即血滤组(21例)、血滤+灌流组(25例)、灌流组(25例)、血浆置换组(25例)。比较治疗前后肝功能、凝血、肾功能的改变。结果血滤组、血滤+灌流组、灌流组3种方法中,治疗前后两两比较,差异无统计学意义(P〉0.05)。以上3组分别与血浆置换组比较,其中灌流组、血滤+灌流组与血浆置换组比较,差异均有统计学意义(P〈0.05);血滤组在改善凝血、降肌酐方面与血浆置换组差异也有统计学意义(P〈0.05)。结论以血液滤过、血液滤过+血液灌流、血液灌流的血液净化方法治疗肝衰竭,均可以达到治疗目的,且可以认为3种方法治疗效果基本相同;血液滤过+血液灌流、血液灌流2种方式与血浆置换方式比较,在降酶、改善凝血状态、降肌酐三方面均存在优势;血液滤过方式与血浆置换治疗方式比较,在改善凝血状态、降肌酐效果上存在优势。 Objective To investigate the efficacy of different blood purification methods for the treatment in liver failure.Methods A total of 96 cases with liver failure were enrolled, which included 59 males and 37 females, aged 36- 73 years old with mean age of 49.46 years old. All of them were divided into 4 groups accorded to different blood purification methods, which were hemofiltration group(HF, n = 21), hemofiltration combined with hemoperfusion group(HF + HP, n = 25), hemoperfusion group(HP, n = 25) and plasmapheresis group(PE, n = 25). The vital signs, liver function, coagulation and renal function changes before and after treatment of 4 groups were compared. Results There were no statistical differences among HF, HF + HP and HP groups(P 〉 0.05), but compared with PE group, there were statistical differences between HF + HP and HP group(P 〈 0.05). Compared with PE group, the HF group showed statistical differences on improvement of coagulation and reduction of creatinine(P 〈 0.05).Conclusion It is demonstrated that the HF, HF + HP and HP are effective methods on treatment of liver failure with same effector. The HF + HP and HP are better than PE on reducing liver enzyme, improving coagulation and reducing creatinine, and HF also shows more efficiency than PE on improving coagulation and reducing creatinine.
出处 《生物医学工程与临床》 CAS 2015年第3期278-284,共7页 Biomedical Engineering and Clinical Medicine
关键词 肝衰竭治疗 血液净化 血液滤过 血液灌流 血浆置换 liver failure blood purification hemofiltration hemoperfusion plasma exchange
  • 相关文献

参考文献5

二级参考文献48

  • 1Xiao-Feng Zhu Gui-Hua Chen Xiao-Shun He Min-Qiang Lu Guo-Dong Wang Chang-Jie Cai Yang Yang Jie-Fu Huang Transplantation Center,The Affiliated First Hospital,Sun Yat-Sen University of Medical Sciences,510080 Guangzhou,Guangdong Province,China.Liver transplantation and artificial liver support in fulminant hepatic failure[J].World Journal of Gastroenterology,2001,7(4):566-568. 被引量:10
  • 2Yi-He Liu, Yu Wang, Li-Xin Yu, Li-Ying Sun, Bao-Lan Feng, Zhong-Yang Shen and Min-Min Wang Tianjin, ChinaTianjin Organ Transplantation Institute, Tianjin First Central Hospital, Tianjin 300192 , China ,Therapeutic Blood Purification Research Cen- ter , University of Rostock, Germany.Artificial liver support molecular adsorbents recirculating system therapy as a bridge to re-transplantation in two cases of long anhepatic duration[J].Hepatobiliary & Pancreatic Diseases International,2004,3(2):316-317. 被引量:1
  • 3饶慧瑛,郭芳,魏来.2005年美国肝病学会急性肝衰竭诊治和肝移植患者评价指南简介[J].中华肝脏病杂志,2006,14(2):154-156. 被引量:22
  • 4Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:829
  • 5Poison J, Lee WM, American Association for the Study of Liver Diseases. AASLD position paper: the management of acute liver failure. Hepatology, 2005, 41 (5) : 1179-1197.
  • 6Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure : consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int, 2009, 3(1 ) : 269-282.
  • 7Lee WM, Stravitz RT, Larsin AM, et al. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology, 2012, 55 ( 3 ) : 965-967.
  • 8Deng G, Zhou G, Zhai Y, et al. Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology, 2004, 40(2) :318-326.
  • 9Yan Z, Tan W, Xu B, et al. A cis-acting regulatory variation of estrogen receptor α ( ESR1 ) gene is associated with hepatitis B virus related liver cirrhosis. Hum Mutat, 2011,32 ( 10 ) : 1128-1136.
  • 10Bernal W, Auzinger G, Dhawan A, et al. Acute liver failure. Lancet, 2010, 376(9736) : 190-201.

共引文献406

同被引文献77

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部